Peptide Tech Review: Pricing, COAs, Testing, and What We Found

An independent evidence review of Peptide Tech covering its former public catalog, multi-lab COA archive, Build-a-Kit discounts, and a material sterility result. Peptide Tech ended its public peptide storefront on August 26, 2026; retained prices are historical.

---

Peptide Tech was curated on PeptideBenchmark because its public surfaces were unusually inspectable: a structured storefront, exact variant stock and pricing, a mixed-product kit program, and a large batch-level certificate library.

Update, August 26, 2026: Peptide Tech announced it was ending its peptide storefront and moving its focus to lyophilization, filling, and later API synthesis, with a remaining white-label fulfillment program. PeptideBenchmark retains the last public prices (observed August 25, 2026) and the previously reviewed COA library as historical records. Those prices are excluded from current Pricing and Stack Builder. This review’s July 27 findings describe the former public storefront; they are not a current checkout claim.

This is our independent evidence review of what the public records established, where the verification chain stopped, and why the presence of a COA should never be treated as a blanket safety signal.

The short version

Peptide Tech has one of the larger public certificate surfaces in the curated vendor set. Its COA library exposed 264 display rows, but those rows did not represent 264 different tests. After grouping repeated product and strength entries by lot and document identity, PeptideBenchmark retained 162 distinct certificate origins.

That distinction is important. Counting every row would overstate the depth of testing by 102 records. Discarding the repeats entirely would also be wrong because the same certificate can have more than one useful product relationship. PB stores the certificate once and keeps its product relationships separately.

The archive spans Freedom Diagnostics, Vanguard Laboratory, Janoshik Analytical, Chromate, and SafeCert. In this review, 104 distinct Freedom reports and six Chromate reports resolved at the issuing laboratory. The remaining documents are still preserved and searchable, but a laboratory name or logo alone does not earn the same badge.

What we found in the catalog

The public storefront yielded 87 parent products and 104 exact variants. PeptideBenchmark preserved the distinctions the store itself publishes:

Catalog result	Count	What it means
Current comparable vial variants	11	In stock, mg-normalized, and suitable for Pricing / Stack Builder
Deferred variants	27	Peptide-adjacent or non-comparable form factors and labels
Out of scope	10	Supplies, devices, or products outside the peptide-vial lane
Currently unavailable variants	56	Suppressed automatically rather than left as stale offers
Build-a-Kit-eligible variants	44	Eligible according to the store’s current public variant configuration

The 11 promoted rows are not intended to represent the entire store. They are the current intersection of in-stock products, supported compound mappings, and comparable labeled quantities. If stock returns or a deferred label becomes unambiguous, the public pipeline can promote it without manually inventing a row.

Current normalized prices from the former catalog are retained as historical observations on PeptideBenchmark Pricing, not as live Stack Builder offers.

The COA archive: 264 rows are not 264 tests

Peptide Tech’s public COA library attaches lot, product, strength, laboratory, date, purity, and document routes to its visible rows. PB performs four separate operations:

1. Enumerate every public library page.
2. Download and byte-validate the linked PDF or image.
3. Collapse repeated display rows to one content-addressed certificate origin.
4. Retain every attributable product relationship separately.

That produced 162 distinct documents from 264 visible rows. The resulting PeptideBenchmark records expose the source document, preserved copy, SHA-256 fingerprint, structured fields, product context, and any independent laboratory-verification route.

Browse the Peptide Tech COA records or use Vial Evidence Check when you have a lot or report identifier.

What “provider-verifiable” means here

The library includes several evidence paths:

• Freedom Diagnostics: PB extracts the accession, provider search code, client, lot, compound, panels, and result fields from the vendor document. A provider badge requires the laboratory-hosted report to resolve and agree with the vendor copy on the identifying fields.
• Janoshik Analytical: both the task number and unique key must resolve through Janoshik’s verifier. The eight historical Janoshik documents in this archive did not resolve at the current verifier, so none received a provider badge.
• Chromate: both the printed job number and access code must resolve through Chromate’s public report route.
• Vanguard Laboratory and SafeCert: the named-lab documents remain source-linked and archived when no independent per-report provider route can be established.

Peptide Tech’s Freedom archive also spans several historical client-name forms—“Peptide Tech,” “Peptide Tech LLC,” “PeptideTech,” and “Peptide Technologies.” PB treats those as an explicit allowlist, not a fuzzy match. Reports with a different client, missing identifier, unavailable provider object, or ambiguous OCR remain unverified.

One certificate reports a failed sterility result

The archive’s breadth surfaced a finding that a simple “COA available” badge would hide. A Vanguard certificate for lot KLW70-4275 reports “Growth Detected” on the sterility panel.

PeptideBenchmark preserves that document and its result. We do not:

• convert the existence of a certificate into a safety endorsement;
• replace a reported failure with the vendor’s catalog-level testing language;
• generalize that single result to every Peptide Tech product; or
• infer what happened after the report without attributable follow-up evidence.

The correct interpretation is narrower: the public archive contains a laboratory document with a material failed result, and readers should be able to see it in exact lot context.

Panel coverage varies by report

Peptide Tech describes broad testing categories across its catalog. The individual documents do not all contain the same panels. Depending on the report, the database may show:

• HPLC purity;
• mass or identity testing;
• net peptide content;
• endotoxin;
• heavy metals; and
• sterility.

A purity result does not answer a sterility question. A heavy-metals panel on one lot does not establish heavy-metals coverage for another. The COA database therefore filters and labels panels at the certificate level, with missing panels shown rather than inferred.

For more context, read What Peptide Testing Can and Cannot Prove.

Build-a-Kit pricing

The public product configuration describes a cart-pooled kit ladder across eligible variants:

• 5 vials: 10% off and a six-vial case;
• 10 vials: 20% off and a deluxe case.

PeptideBenchmark models the percentage discounts because they affect the comparable product subtotal. The cases are recorded as non-price benefits. Eligibility comes from the current per-variant kitMaxUnits data, which prevents an ineligible or unavailable product from silently inheriting the tier.

No PeptideBenchmark affiliate code exists, and coupon composition was not independently cart-certified. The optimizer therefore applies the audited tier without inventing additional stacking.

Shipping

Peptide Tech’s shipping policy provides free domestic ground shipping at $200, calculated after discounts and before tax. Shipping remains outside PB’s normalized item-price ranking because destination and checkout conditions can change the final amount.

Bottom line

Peptide Tech earned curated coverage because its public data supports a real evidence record: structured products, current stock, explicit kit eligibility, and 162 distinct certificate documents across five named laboratories.

The best part of that record is not the raw document count. It is the ability to separate a source-linked document from an independently resolved report, one certificate from its repeated display relationships, and a passed panel from a failed one. The most important finding—the Vanguard sterility failure—is exactly why a COA database should preserve results rather than merely count PDFs.

Readers can inspect the Peptide Tech profile and search its retained COA records. Dated prices remain in the historical table on Pricing. The former BENCHMARK referral storefront is not a current retail checkout.

Common questions

Is Peptide Tech legitimate?

PeptideBenchmark does not issue binary legitimacy or product-safety endorsements. We confirmed a public 87-product storefront, exact variant pricing and stock data, and 162 distinct public certificate documents after duplicate library rows were collapsed. A substantial subset of the reports also resolves at the issuing laboratory. Those facts support the authenticity of the documented evidence, not every physical vial.

Are Peptide Tech COAs independently verifiable?

Many are. In the July 27 review, 104 distinct Freedom Diagnostics reports and six Chromate reports resolved through the issuing laboratory with matching identifiers and vendor or client context. Eight older Janoshik documents did not resolve at Janoshik's current verifier, while Vanguard and SafeCert documents had no independent per-report lookup; those remain named-lab, vendor-hosted evidence.

Does Peptide Tech test for sterility, endotoxin, and heavy metals?

Some reports include those panels, but coverage varies by certificate. Readers should inspect the exact lot record rather than generalize a panel from one certificate to the full catalog. One Vanguard certificate in the July 27 review reported growth detected on its sterility panel.

How does Peptide Tech's Build-a-Kit discount work?

The public product configuration publishes a mixed-product eligible-vial ladder: five vials receive 10% off and ten receive 20% off. Eligible variants are explicit and can change with inventory. Coupon composition was not independently verified, so PeptideBenchmark does not stack an assumed code.

Does PeptideBenchmark have an affiliate relationship with Peptide Tech?

PeptideBenchmark established a disclosed affiliate relationship with Peptide Tech on July 30, 2026. The former BENCHMARK referral link applied 10% automatically while the public storefront was open. Peptide Tech ended that storefront on August 26, 2026, so the referral is not a current retail checkout path. The relationship began after the evidence review and does not alter its findings, trust score, or placement.